1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Doxorubicin Market – By Drug Formulation

1.3.2        APAC Doxorubicin Market – By Application

1.3.3        APAC Doxorubicin Market – By Distribution Channel

1.3.4        APAC Doxorubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Doxorubicin Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Expert Opinion

5.           APAC Doxorubicin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Increasing Preference for Chemotherapy

5.2         Market Restraints

5.2.1        Potential Side-effects Associated with Doxorubicin

5.3         Market Opportunities

5.3.1        Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention

5.4         Future Trends

5.4.1        Increasing Approval of Generic Products

5.5         Impact Analysis

6.           Doxorubicin Market– APAC Analysis

6.1         APAC Doxorubicin Market Revenue Forecast and Analysis

7.           APAC Doxorubicin Market Analysis – By Drug Formulation

7.1         Overview

7.2         APAC Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)

7.3         Lyophilized Powder

7.3.1        Overview

7.3.2        Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

7.4         Doxorubicin Injection

7.4.1        Overview

7.4.2        Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.           APAC Doxorubicin Market Analysis – By Application

8.1         Overview

8.2         APAC Doxorubicin Market Share, By Application 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.4         Kidney Cancer

8.4.1        Overview

8.4.2        Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.5         Liver Cancer

8.5.1        Overview

8.5.2        Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.6         Sarcoma

8.6.1        Overview

8.6.2        Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.7         Ovarian Cancer

8.7.1        Overview

8.7.2        Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.8         Lung Cancer

8.8.1        Overview

8.8.2        Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.9         Leukemia

8.9.1        Overview

8.9.2        Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.10      Multiple Myeloma

8.10.1     Overview

8.10.2     Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.11      Others

8.11.1     Overview

8.11.2     Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.           APAC Doxorubicin Market Analysis – By Disribution Channel

9.1         Overview

9.2         APAC Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

10.        APAC Doxorubicin Market Analysis – By Country

10.1      Overview

10.1.1     APAC: Doxorubicin Market, by Country, 2022 & 2028 (%)

10.1.1.1       China: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       China: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.2       China: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)

10.1.1.1.3       China: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.4       China: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)

10.1.1.2       Japan: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Japan: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.2       Japan: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)

10.1.1.2.3       Japan: Doxorubicin Market, By Application, 2019–2028 (US$ Million)

10.1.1.2.4       Japan: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)

10.1.1.3       India: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       India: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.2       India: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)

10.1.1.3.3       India: Doxorubicin Market, By Application, 2019–2028 (US$ Million)

10.1.1.3.4       India: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)

10.1.1.4       South Korea: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       South Korea: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.2       South Korea: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)

10.1.1.4.3       South Korea: Doxorubicin Market, By Application, 2019–2028 (US$ Million)

10.1.1.4.4       South Korea: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)

10.1.1.5       Australia: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Australia: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.2       Australia: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)

10.1.1.5.3       Australia: Doxorubicin Market, By Application, 20192028 (US$ Million)

10.1.1.5.4       Australia: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)

10.1.1.6       Rest of APAC: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Rest of APAC: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.2       Rest of APAC: Doxorubicin Market, By Drug Formulation, 2019–2028 (US$ Million)

10.1.1.6.3       Rest of APAC: Doxorubicin Market, By Application, 2019–2028 (US$ Million)

10.1.1.6.4       Rest of APAC: Doxorubicin Market, By Distribution Channel, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Accord Healthcare

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Cipla Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Meiji Holdings Co., Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Novartis AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Pfizer Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Sun Pharmaceutical Industries Ltd

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Baxter International Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Zydus Cadila

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             APAC Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Incidence, Mortality, and Prevalence, by Cancer Site (2020)

Table 3.             China: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China: Doxorubicin Market, by Application – Revenue and forecast to 2028 (US$ Million)

Table 5.             China: Doxorubicin Market, By Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Japan: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Japan: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Japan: Doxorubicin Market, By Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Incidence, Mortality, and Prevalence by Cancer Site (2020)

Table 10.          India: Doxorubicin Market, By Drug Formulation– Revenue and Forecast to 2028 (US$ Million)

Table 11.          India: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          India: Doxorubicin Market, By Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 13.          South Korea: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 14.          South Korea: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 15.          South Korea: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

Table 16.          Australia: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Australia: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Australia: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of APAC: Doxorubicin Market, By Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Rest of APAC: Doxorubicin Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of APAC: Doxorubicin Market, By Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

Table 22.          Organic Developments Done By Companies

Table 23.          Inorganic Developments Done by Companies

Table 24.          Glossary of Terms

LIST OF FIGURES

Figure 1.           APAC Doxorubicin Market Segmentation

Figure 2.           APAC Doxorubicin Market Segmentation, By Country

Figure 3.           APAC Doxorubicin Market Overview

Figure 4.           APAC Doxorubicin Market, By Drug Formulation

Figure 5.           APAC Doxorubicin Market, By Country

Figure 6.           APAC: PEST Analysis

Figure 7.           APAC Doxorubicin Market Impact Analysis Of Driver And Restraints

Figure 8.           APAC Doxorubicin Market– Revenue Forecast and Analysis

Figure 9.           APAC Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)

Figure 10.        APAC Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 11.        APAC Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 12.        APAC Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)

Figure 13.        APAC Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        APAC Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        APAC Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 16.        APAC Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        APAC Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        APAC Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        APAC Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        APAC Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 21.        APAC Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        APAC Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)

Figure 23.        APAC Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        APAC Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 25.        APAC Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 26.        APAC Doxorubicin Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27.        APAC: Doxorubicin Market, by Country, 2022 & 2028 (%)

Figure 28.        China: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Japan: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        India: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South Korea: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Australia: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Rest of APAC: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)